Skip to main content

Table 2 The compliance before, 6, 12, and 24 months after the implementation of clinical guidelines for depression in % (n).

From: Supported local implementation of clinical guidelines in psychiatry: a two-year follow-up

  Implementation clinics Control clinics
Indicator % (n) OR (95% CI) % (n) OR (95% CI)
Accessibility/wait time     
   0 months 77.9 (95) reference 59.0 (36) reference
   6 months 89.2 (107) 2.4 (1.1-5.2) 53.3 (32) 0.6 (0.3-1.4)
   12 months 97.1 (233) 13.4 (5.3-34.0) 44.2 (53) 0.4 (0.2-0.9)
   24 months 90.0 (216) 2.5 (1.3-4.9) 51.7 (62) 0.6 (0.3-1.2)
Diagnostic assessment     
   0 months 83.6 (102) reference 88.5 (54) reference
   6 months 97.5 (117) 9.6 (2.5-36.1) 90.0 (54) 1.1 (0.4-3.6)
   12 months 97.5 (234) 11.1 (4.0-30.9) 83.3 (100) 0.6 (0.3-1.6)
   24 months 97.9 (235) 10.9 (3.7-32.4) 79.2 (95) 0.5 (0.2-1.2)
Diagnostic instrument     
   0 months 12.3 (15) reference 1.6 (1) reference
   6 months 28.3 (34) 2.8 (1.4-5.5) 0 na
   12 months 41.3 (99) 5.3 (2.9-9.7) 0.8 (1) na
   24 months 44.2 (106) 5.7 (3.1-10.5) 0.8 (1) na
Standardized rating scale     
   0 months 64.8 (79) reference 44.3 (27) reference
   6 months 91.7 (110) 6.2 (2.9-13.3) 33.3 (20) 0.7 (0.3-1.4)
   12 months 95.0 (228) 11.1 (5.5-22.3) 37.5 (45) 0.8 (0.4-1.5)
   24 months 94.2 (226) 9.1 (4.7-17.6) 36.7 (44) 0.7 (0.4-1.4)
Standardized rating scale during treatment     
   0 months 50.0 (61) reference 24.6 (15) reference
   6 months 87.5 (105) 7.6 (3.9-14.9) 38.3 (23) 1.9 (0.8-4.2)
   12 months 97.5 (234) 47.5 (19.0-118.2) 30.8 (37) 1.4 (0.7-2.8)
   24 months 88.3 (212) 8.1 (4.7-14.3) 33.3 (40) 1.5 (0.8-3.1)
Substance/drug abuse     
   0 months 46.7 (57) reference 32.8 (20) reference
   6 months 87.5 (105) 8.0 (4.2-15.4) 53.2 (32) 2.8 (1.3-6.2)
   12 months 94.2 (226) 18.5 (9.7-35.4) 35.0 (42) 1.2 (0.6-2.3)
   24 months 88.8 (213) 9.1 (5.3-15.6) 43.3 (52) 1.8 (0.9-3.6)
Treatment (care) plan     
   0 months 59.8 (73) reference 42.6 (26) reference
   6 months 87.5 (105) 5.5 (2.7-11.1) 38.3 (23) 0.9(0.4-1.9)
   12 months 90.4 (217) 8.4 (4.5-15.5) 34.2 (41) 0.7 (0.4-1.4)
   24 months 91.3 (219) 8.1 (4.3-15.0) 27.5 (33) 0.5 (0.3-1.0)
Evaluation/outcome     
   0 months 66.4 (81) reference 59.0 (36) reference
   6 months 95.8 (115) 11.9 (4.5-31.7) 55.0 (33) 0.8 (0.4-1.7)
   12 months 97.5 (234) 20.3 (8.2-49.9) 48.3 (58) 0.6 (0.3-1.1)
   24 months 95.8 (230) 11.9 (5.7-25.0) 48.3 (58) 0.6 (0.3-1.1)
Continuity     
   0 months 77.0 (94) reference 78.7 (48) reference
   6 months 95.0 (114) 5.6 (2.2-14.1) 61.7 (37) 0.4 (0.2-1.1)
   12 months 99.6 (239) 72.0 (9.7-537.4) 71.7 (86) 0.7 (0.3-1.5)
   24 months 95.8 (230) 6.7 (3.1-14.4) 68.3 (82) 0.6 (0.3-1.4)
Suicide assessment     
   0 months 40.2 (49) reference 45.9 (28) reference
   6 months 95.8 (115) 36.1 (13.5-96.5) 35.0 (21) 0.6 (0.3-1.4)
   12 months 93.8 (225) 23.3 (12.1-44.7) 35.8 (43) 0.7 (0.4-1.2)
   24 months 97.5 (234) 61.3 (24.8-151.9) 30.0 (36) 0.5 (0.3-1.0)
Antidepressant medication     
   0 months 54.1 (66) reference 45.9 (28) reference
   6 months 90.8 (109) 8.3 (4.1-17.0) 36.7 (22) 0.7 (0.3-1.4)
   12 months 85.4 (205) 5.0 (3.0-8.2) 44.2 (53) 1.0 (0.5-1.7)
   24 months 92.5 (222) 10.3 (5.7-18.8) 41.7 (50) 0.8 (0.4-1.5)
  1. na The numbers did not allow calculations.
  2. Odds ratios adjusted for age and gender with baseline as the reference is presented with CI (95%)